498 related articles for article (PubMed ID: 25879158)
1. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
Martínez-Barricarte R; Heurich M; López-Perrote A; Tortajada A; Pinto S; López-Trascasa M; Sánchez-Corral P; Morgan BP; Llorca O; Harris CL; Rodríguez de Córdoba S
Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
Mohlin FC; Nilsson SC; Levart TK; Golubovic E; Rusai K; Müller-Sacherer T; Arbeiter K; Pállinger É; Szarvas N; Csuka D; Szilágyi Á; Villoutreix BO; Prohászka Z; Blom AM
Mol Immunol; 2015 Jun; 65(2):367-76. PubMed ID: 25733390
[TBL] [Abstract][Full Text] [Related]
3. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
[TBL] [Abstract][Full Text] [Related]
4. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
[TBL] [Abstract][Full Text] [Related]
5. Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.
Schramm EC; Roumenina LT; Rybkine T; Chauvet S; Vieira-Martins P; Hue C; Maga T; Valoti E; Wilson V; Jokiranta S; Smith RJ; Noris M; Goodship T; Atkinson JP; Fremeaux-Bacchi V
Blood; 2015 Apr; 125(15):2359-69. PubMed ID: 25608561
[TBL] [Abstract][Full Text] [Related]
6. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
[TBL] [Abstract][Full Text] [Related]
7. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP
Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
Szarvas N; Szilágyi Á; Csuka D; Takács B; Rusai K; Müller T; Arbeiter K; Réti M; Haris Á; Wagner L; Török S; Kelen K; Szabó AJ; Reusz GS; Morgan BP; Prohászka Z
Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
[TBL] [Abstract][Full Text] [Related]
9. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
Osborne AJ; Breno M; Borsa NG; Bu F; Frémeaux-Bacchi V; Gale DP; van den Heuvel LP; Kavanagh D; Noris M; Pinto S; Rallapalli PM; Remuzzi G; Rodríguez de Cordoba S; Ruiz A; Smith RJH; Vieira-Martins P; Volokhina E; Wilson V; Goodship THJ; Perkins SJ
J Immunol; 2018 Apr; 200(7):2464-2478. PubMed ID: 29500241
[TBL] [Abstract][Full Text] [Related]
10. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
Bresin E; Rurali E; Caprioli J; Sanchez-Corral P; Fremeaux-Bacchi V; Rodriguez de Cordoba S; Pinto S; Goodship TH; Alberti M; Ribes D; Valoti E; Remuzzi G; Noris M;
J Am Soc Nephrol; 2013 Feb; 24(3):475-86. PubMed ID: 23431077
[TBL] [Abstract][Full Text] [Related]
11. Complement activation in diseases presenting with thrombotic microangiopathy.
Meri S
Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.
Józsi M; Reuter S; Nozal P; López-Trascasa M; Sánchez-Corral P; Prohászka Z; Uzonyi B
Immunol Lett; 2014 Aug; 160(2):163-71. PubMed ID: 24491679
[TBL] [Abstract][Full Text] [Related]
13. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome.
Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP
J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990
[TBL] [Abstract][Full Text] [Related]
14. Genetics of atypical hemolytic uremic syndrome (aHUS).
Rodríguez de Córdoba S; Hidalgo MS; Pinto S; Tortajada A
Semin Thromb Hemost; 2014 Jun; 40(4):422-30. PubMed ID: 24799305
[TBL] [Abstract][Full Text] [Related]
15. Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree.
Esparza-Gordillo J; Jorge EG; Garrido CA; Carreras L; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
Mol Immunol; 2006 Apr; 43(11):1769-75. PubMed ID: 16386793
[TBL] [Abstract][Full Text] [Related]
16. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.
Volokhina E; Westra D; Xue X; Gros P; van de Kar N; van den Heuvel L
Pediatr Nephrol; 2012 Sep; 27(9):1519-24. PubMed ID: 22669319
[TBL] [Abstract][Full Text] [Related]
17. Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes.
Le Quintrec M; Roumenina L; Noris M; Frémeaux-Bacchi V
Semin Thromb Hemost; 2010 Sep; 36(6):641-52. PubMed ID: 20865641
[TBL] [Abstract][Full Text] [Related]
18. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.
Roumenina LT; Frimat M; Miller EC; Provot F; Dragon-Durey MA; Bordereau P; Bigot S; Hue C; Satchell SC; Mathieson PW; Mousson C; Noel C; Sautes-Fridman C; Halbwachs-Mecarelli L; Atkinson JP; Lionet A; Fremeaux-Bacchi V
Blood; 2012 May; 119(18):4182-91. PubMed ID: 22246034
[TBL] [Abstract][Full Text] [Related]
19. Genetic and Protein Structural Evaluation of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
Perkins SJ
Adv Chronic Kidney Dis; 2020 Mar; 27(2):120-127.e4. PubMed ID: 32553244
[TBL] [Abstract][Full Text] [Related]
20. Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.
Liszewski MK; Leung MK; Schraml B; Goodship TH; Atkinson JP
Mol Immunol; 2007 Mar; 44(7):1559-68. PubMed ID: 17027083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
